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OBJECTIVE — With increasing evidence about the cardiovascular risk associated with post-
prandial nonfasting glucose and lipid dysmetabolism, it remains uncertain whether the post-
prandial glucose concentration increases the ability of metabolic syndrome to predict
cardiovascular events.
RESEARCH DESIGN AND METHODS — This was an observational study of 15,145
individuals aged 35–75 years without diabetes or cardiovascular diseases. Postprandial glucose
was obtained 2 h after a lunch meal. Metabolic syndrome was diagnosed using the criteria of the
U.S. National Cholesterol Education Program Adult Treatment Panel III. Cardiovascular and
all-cause deaths were primary outcomes.
RESULTS — During a median follow-up of 6.7 years, 410 individuals died, including 82
deaths from cardiovascular causes. In a Cox model adjusting for metabolic syndrome status as
wellasage,sex,smoking,systolicbloodpressure,LDL,andHDLcholesterollevels,elevated2-h
postprandial glucose increased the risk of cardiovascular and all-cause death (per millimole per
liter increase, hazard ratio 1.26 [95% CI 1.11–1.42] and 1.10 [1.04–1.16], respectively), with
signiﬁcant trends across the postprandial glucose quintiles. Including 2-h postprandial glucose
into a metabolic syndrome–included multivariate risk prediction model conferred a discernible
improvement of the model in discriminating between those who died of cardiovascular causes
and who did not (integrated discrimination improvement 0.4, P  0.005; net reclassiﬁcation
improvement 13.4%, P  0.03); however, the improvement was only marginal for all-cause
death.
CONCLUSIONS — Giventheriskpredictionbasedonmetabolicsyndromeandestablished
cardiovascular risk factors, 2-h postprandial glucose improves the predictive ability to identity
nondiabetic individuals at increased risk of cardiovascular death.
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P
roposed in 1988 by Reaven (1), the
constructthatimpairedglucosereg-
ulationandinsulinresistancetoglu-
cose stimulation frequently coexist with
elevated blood pressure and dyslipidemia
has been evolving into several diagnostic
criteria of metabolic syndrome (2–4), a
well-established risk for development of
cardiovasculareventsandtype2diabetes.
Of those, the deﬁnitions recommended
by the U.S. National Cholesterol Educa-
tion Program Adult Treatment Panel III
(ATP III) (2) and the International Diabe-
tes Federation (IDF) (3) are the most
widely used, partly because only fasting
glucose and lipid concentrations are re-
quired. It has been increasingly recog-
nized that postprandial glucose might be
a better risk predictor for cardiovascular
eventsthanfastingglucoseinnondiabetic
and diabetic populations alike (5). A
study using conﬁrmatory factor analysis
indicated that postprandial glucose ap-
peared to be more correlated with meta-
bolic syndrome than fasting glucose (6).
However, concerns have not been fully
addressed for whether elevated postpran-
dialglucosewouldincreasetheriskofad-
verse outcomes of metabolic syndrome
diagnosedaccordingtotheATPIIIorIDF
criteria.
Although postprandial glucose is tra-
ditionally obtained using an oral glucose
tolerance test (OGTT), accumulating evi-
denceshowsthatpostprandialglucoseaf-
ter a mixed meal might be more likely to
reﬂect physiological responses to a glu-
cose challenge in daily life than an OGTT
(7,8).Therefore,theaimofthisstudywas
to examine the relationship of postmeal
postprandial glucose with cardiovascular
and all-cause deaths in nondiabetic
individuals.
RESEARCH DESIGN AND
METHODS— A prospective observa-
tional cohort enrolled 17,299 self-
referred individuals aged 30–75 years,
who attended health examinations at the
National Taiwan University Hospital be-
tweenJanuary1995andDecember2002.
At baseline, structured questionnaires
were used to collect family history, cur-
rent smoking status, and medical histo-
ries. We excluded individuals with
diabetesorwithamedicalhistoryofmyo-
cardial infarction, coronary heart disease,
stroke, carotid artery stenosis, or periph-
eral artery disease at baseline. Diabetes
was deﬁned if one of following existed:
current use of antidiabetic agents, diet
modiﬁcations because of diabetes, fasting
glucose 7.0 mmol/l (126 mg/dl), or 2-h
postprandial glucose 11.1 mmol/l (200
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had incomplete baseline data, missing
fasting glucose or 2-h postprandial glu-
cose data, severely impaired renal func-
tion (serum creatinine levels 530
mol/l [6 mg/dl]), or comorbidity with
cancer. Accordingly, we included a total
of 6,024 women and 9,121 men for the
analysis. The study protocol was ap-
proved by the hospital’s institutional re-
view board.
Laboratory measurements
Venous blood samples were collected
from each participant after at least a 12-h
overnight fast, and 2-h postprandial glu-
cose was obtained 2 h after a standard
650-kcal lunch meal, which was com-
posed of 110 g carbohydrates, 27–30 g
protein, and 8–10 g fat. Total cholesterol
levels were measured using the CHOD-
PAP method (Boehringer Mannheim,
Mannheim, Germany), and HDL choles-
terol was measured after precipitation of
apolipoprotein B–containing lipopro-
teins, with phosphotungstic acid and
magnesium ions (Boehringer Mann-
heim). Triglyceride concentrations were
measured by the GPO-DAOS method
(Wako Pure Chemicals, Tokyo, Japan).
LDL cholesterol concentrations were cal-
culated using the Friedewald formula.
Plasma fasting glucose and 2-h postpran-
dial glucose concentrations were mea-
sured using a Hitachi 7450 automated
analyzer (Hitachi, Tokyo, Japan). A1C
wasmeasuredusingaDCA2000analyzer
(Bayer Diagnostics, Elkhart, IN).
Deﬁnition of metabolic syndrome
and postprandial hyperglycemia
Of the criteria available for diagnosis of
metabolic syndrome, the two recom-
mended by the IDF and ATP III, respec-
tively, do not require postprandial
glucoseasaclinicalmeasurementofinsu-
lin resistance. Because a previous study
has proved substantial agreement be-
tween the ATP III and IDF criteria (9), we
did not assess the effects of the IDF crite-
ria on the results of this study.
Metabolic syndrome was deﬁned us-
ing the modiﬁed ATP III deﬁnition (9).
Individuals with three or more of the fol-
lowing ﬁve criteria are regarded as having
metabolic syndrome: 1)B M Io f27
kg/m
2 for an Asian population (10); 2)
systolic blood pressure 130 mmHg or
diastolic blood pressure 85 mmHg; 3)
fasting plasma glucose 6.1 mmol/l (100
mg/dl); 4) triglyceride level 1.69
mmol/l (150 mg/dl); and 5) HDL choles-
terol level 1.29 mmol/l (50 mg/dl) for
women or 1.04 mmol/l (40 mg/dl) for
men. Individuals with a 2-h postprandial
glucoseof7.8mmol/l(140mg/dl)were
deﬁned as having postprandial hypergly-
cemia,becausethosewithnormalglucose
regulation rarely have a plasma glucose
level of 7.8 mmol/l (140 mg/dl) or
higher (11).
Ascertainment of the causes of death
Mortality and causes of death were ascer-
tained according to a national register
database, which was provided by the
National Health Administration, and
wasupdatedattheendof2007,bylink-
ing identiﬁcation numbers of individu-
als to the database. Cardiovascular
death was deﬁned as deaths from car-
diovascular causes if the registered
death codes ranged from 390 to 459,
based on ICD-9.
Statistical analysis
Data are summarized as means  SD for
continuous variables and as percentages
for categorical variables. Baseline charac-
teristics are represented by quintiles of
2-h postprandial glucose, and differences
among quintile groups were tested with
ANOVA for mean values and by the 
2
test for categorical values. The Cox pro-
portional hazards regression model was
applied to assess the association of 2-h
postprandial glucose with the incidence
of cardiovascular death and all-cause
death after adjustment for covariates as
follows: model 1, age-groups (35–44,
45–54, 55–64, 65–74, and 75 years
old), sex, and current smoker (yes/no);
Table 1—Baseline characteristics among 6,024 women and 9,121 men according to the quintiles of 2-h postprandial glucose
Total
2-h postprandial glucose quintile
Q1
(5.16)
Q2
(5.16–5.76)
Q3
(5.77–6.37)
Q4
(6.38–7.32)
Q5
(7.33)
n 15,145 2,887 2,985 3,043 3,220 2,873
Age (years) 52.9  10.2 50.9  10.6 51.0  10.0 52.3  9.9 54.1  9.7 55.9  10.0
Sex (women) 6,024 (40) 1,072 (37) 1,248 (42) 1,250 (41) 1,272 (40) 1,182 (39)
Current smoker 3,865 (26) 791 (27) 727 (24) 739 (24) 790 (25) 818 (27)
ATP III–deﬁned metabolic syndrome 2,590 (17) 303 (11) 359 (12) 493 (16) 606 (19) 829 (28)
BMI (kg/m
2) 24.3  3.1 23.6  3.0 24.0  3.1 24.3  3.1 24.5  3.1 25.0  3.2
Systolic blood pressure (mmHg) 115.0  28.4 105.7  29.5 115.6  25.0 117.8  25.0 118.6  27.8 116.6  32.2
Laboratory measurements
Total cholesterol (mmol/l) 5.03  0.93 4.89  0.91 4.99  0.90 5.08  0.94 5.05  0.93 5.09  0.93
Triglycerides (mmol/l) 1.47  0.96 1.30  0.80 1.39  0.84 1.46  1.11 1.51  0.93 1.68  1.02
HDL cholesterol (mmol/l) 1.28  0.36 1.31  0.37 1.31  0.37 1.30  0.36 1.27  0.35 1.22  0.35
LDL cholesterol (mmol/l) 3.09  0.82 2.97  0.82 3.06  0.80 3.14  0.84 3.13  0.82 3.13  0.82
A1C (%) 5.28  0.54 5.19  0.49 5.16  0.46 5.22  0.46 5.30  0.51 5.50  0.67
Fasting glucose (mmol/l) 5.10  0.51 4.94  0.45 5.02  0.42 5.08  0.45 5.16  0.50 5.31  0.61
2-h plasma glucose (mmol/l) 6.30  1.46 4.50  0.60 5.45  0.17 6.04  0.17 6.81  0.28 8.56  0.98
Clinical outcomes, per 10,000 person-years
Cardiovascular death 7.1 5.5 3.7 4.5 5.8 15.2
All-cause death 35.3 31.2 26.6 26.1 28.5 62.1
Data for continuous variables are means  SD; data for categorical variables are n (%). P values of all variables listed were 0.05 across the quintile groups. BMI
calculated as weight in kilograms divided by the square of height in meters.
Postprandial glucose and death
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blood pressure (quintile groups), HDL
cholesterol (quintile groups), and LDL
cholesterol (quintile groups); and model
3, metabolic syndrome (presence/
absence) was added into model 2. P val-
ues for linear trend were calculated with
the median from each quintile group.
To further evaluate the improvement
in predictive ability of metabolic syn-
drome for cardiovascular and all-cause
death after 2-h postprandial glucose was
added to multivariate Cox models, we
compared the measures of discrimination
and calibration between the models with
and without 2-h postprandial glucose.
Three methods were used to assess the
extent to which 2-h postprandial glucose
increased the discriminative performance
of risk prediction. The ﬁrst was to com-
pare the differences of the area under the
receiver operating characteristic curves
(AUC) between risk prediction models
with and without 2-h postprandial glu-
cose. Receiver operating characteristic
curves were constructed by plotting sen-
sitivityversus1speciﬁcityobtainedus-
ing multivariate logistic regression, and
AUCs were compared using a nonpara-
metric test (12).
Because AUC values may not be sen-
sitiveenoughtoexpresstheimprovement
of discrimination performance, we also
used two other methods: net reclassiﬁca-
tion improvement (NRI) and integrated
discrimination improvement (IDI) as de-
scribed by Pencina et al. (13). Based on
the prior predictive risk, individuals were
classiﬁed into four risk categories of
0–1%, 1–3%, 3–6%, and 6% derived
from a probability distribution of 5-year
risk for cardiovascular death (14) and
then were reclassiﬁed according to the
predictive risks in regression models in-
cluding 2-h postprandial glucose. The
NRI was the difference between the per-
centage of reclassifying those with
events into higher risk categories and
thosewithouteventsintolowerriskcat-
egories (indicating improvement in the
discrimination performance) and the
percentage of reclassifying those with
eventsintolowerriskcategoriesandthose
without events into higher risk categories
(indicatingfailuretoimprovethediscrim-
ination performance). The overall reclas-
siﬁcation improvement was statistically
examinedbyanasymptotictest(13).Sim-
ilarly, individuals were grouped into four
categoriesof0–10%,1025%,25–35%,
and 35%, which were deﬁned on the
assumptionthatcardiovasculardeathwas
accountable for 15% of all-cause death
according to the 2006 mortality statistics
from the World Health Organization. Be-
cause the clinical consensus on risk cut-
offsforcardiovascularandall-causedeath
has not been established, the IDI was ap-
plied to estimate the discrimination im-
provement in average sensitivity and any
potential increase in average 1 speciﬁc-
ityandwasexaminedusinganasymptotic
test (13).
Model calibration was assessed with
the Hosmer-Lemeshow goodness-of-ﬁt

2 statistic, a measure of discrepancy de-
scribing how well the predicted probabil-
ities ﬁt observed outcomes. A model with
a smaller Hosmer-Lemeshow statistic is
better calibrated, whereas a model with a
statistic of 20 is regarded as having a
lack of calibration (15).
The metabolic syndrome by a post-
prandial hyperglycemia interaction term
was used in a multivariate Cox model to
explore the effect modiﬁcation of meta-
bolic syndrome with postprandial hyper-
glycemiaonriskofcardiovascularandall-
cause death, and multivariate-adjusted
relative risks of primary outcomes were
plotted by stratiﬁcation.
All statistical tests were two-tailed
with a type I error of 0.05, and P  0.05
was regarded as statistically signiﬁcant.
All of the statistical analyses were per-
formed with SAS (version 9.1; SAS Insti-
tute, Cary, NC) and Stata (version 10;
StataCorp, College Station, TX).
RESULTS
Baseline characteristics
As summarized in Table 1, with increas-
ing quintiles of 2-h postprandial glucose,
individuals were more likely to have a
higher prevalence of ATP III metabolic
syndrome, higher total cholesterol, triglyc-
erides,LDLcholesterol,fastingglucose,and
A1C, but lower HDL cholesterol.
Postprandial blood glucose as a
predictor for cardiovascular and
all-cause death independently of
metabolic syndrome
Of the 15,145 nondiabetic participants,
410 died during a median follow-up of 6.7
years(interquartilerange3.3years),includ-
ing 82 deaths from cardiovascular causes.
As outlined in Table 2, after adjustment for
sex, age, smoking status, systolic blood
pressure,andLDLandHDLcholesterolina
Cox model, elevated 2-h postprandial glu-
cose was associated with increased risks of
cardiovascular and all-cause death (hazard
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vascular death; 1.10 [1.03–1.16] for all-
cause death). Furthermore, additional
adjustment for the presence or absence of
metabolic syndrome maintained the inde-
pendent association between 2-h postpran-
dial glucose and risks of cardiovascular and
all-cause death. Moreover, the trends to-
wardheightenedrisksofprimaryoutcomes
were also found to be signiﬁcant across the
increasingquintilesof2-hpostprandialglu-
cose. Compared with the absence of post-
prandial hyperglycemia (Fig. 1), the
presence of postprandial hyperglycemia
raised the relative risk of 2.22 (95% CI
1.40–3.52) for cardiovascular death and of
1.56 (1.25–1.94) for all-cause death. There
was no evidence of substantial heterogene-
ity in relative risks of primary outcomes as-
sociated with postprandial hyperglycemia
between subgroups with or without meta-
bolic syndrome.
Comparison in discrimination and
calibration between metabolic
syndrome–included multivariate
prediction models before and after
adding 2-h postprandial glucose
Table 3 and supplementary Tables A1 and
A2(availableinanonlineappendixathttp://
care.diabetesjournals.org/cgi/content/full/
dc08-2337/DC1) present a summary of
the statistics for the evaluation of the
model discrimination performance and
calibration. Although AUC values mar-
ginally increased after 2-h postprandial
glucose was incorporated in the meta-
bolic syndrome–included multivariate-
adjusted models (Table 3), we observed
signiﬁcant improvements using the NRI
andIDImethods.Usingthepredictedrisk
obtained from the metabolic syndrome–
included prediction model incorporating
2-h postprandial glucose (supplementary
TableA1),wefoundthat,of82cardiovas-
cular deaths, 17 individuals with events
were reclassiﬁed into higher risk catego-
ries, whereas 6 were classiﬁed into lower
risk categories; accordingly, the reclassi-
ﬁcation improvement was 13.4% ([17 
6/82] 
 100%). However, in 14,901 in-
dividuals who did not die of cardiovascu-
lar disease (supplementary Table A2),
558 were designated as lower risk and
567 as higher risk, thereby indicating
0.0% ([558  567/14,901] 
 100%) in
reclassiﬁcation improvement. Therefore,
the NRI was 13.4% (95% CI 2.2–24.5,
P0.02),suggestingthattheriskpredic-
tion for cardiovascular death improved
after 2-h postprandial glucose was added
into the model. Although the clinical im-
plication of the absolute value of IDI
awaits further clariﬁcation, the improve-
ment in discrimination performance in
the prediction model for cardiovascular
death after addition of 2-h postprandial
Figure 1—Association of postprandial hyperglycemia with the risk of cardiovascular and all-cause death according to the presence or absence of
metabolic syndrome. Postprandial hyperglycemia was deﬁned as 2-h postprandial glucose 7.8 mmol/l (140 mg/dl). Relative risk was adjusted for
age-groups(35–44,45–54,55–64,65–74,and75years),sex,smokingstatus(yes/no),systolicbloodpressure(quintilegroups),HDLcholesterol
(quintilegroups),andLDLcholesterol(quintilegroups)inaCoxproportionalhazardsanalysis.Thedashedverticallinesrepresentthecorrespond-
ing overall point estimates, and the solid horizontal lines represent the 95% CI. Pinteraction was obtained by the interaction test between metabolic
syndrome and postprandial hyperglycemia.
Table 3—Improvement in discrimination performance and calibration for risk prediction of cardiovascular death and all-cause death in the
multivariate-adjusted model after including 2-h postprandial glucose
AUC IDI (%) NRI (%) Calibration, 
2*
Cardiovascular death
Established risk factors 	 MetS† 0.81 (0.77–0.85) Referent Referent 10.6
Established risk factors 	 MetS 	 2-h PG† 0.82 (0.79–0.86) 0.4 (0.1–0.7)§ 13.4 (2.2–24.5)‡ 6.3
All-cause death
Established risk factors 	 MetS† 0.77 (0.75–0.80) Referent Referent 11.0
Established risk factors 	 MetS 	 2-h PG† 0.78 (0.75–0.80) 0.2 (0.0–0.3)‡ 3.6 (1.2–6.0)§ 8.1
Data are values (95% CI). *Values were obtained using the Hosmer-Lemeshow test.
†Established risk factors included age, sex, smoking status, systolic blood pressure, HDL cholesterol, and LDL cholesterol for adjustment. ‡P  0.05; §P  0.01.
MetS, metabolic syndrome; PG, postprandial glucose.
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timate of IDI of 0.4% (95% CI 0.1–0.7,
P  0.005), which might, however, be
more pertinent than NRI when a consen-
sus on clinical risk categories has not be
established. Likewise, for all-cause death,
NRI was 3.6% (95% CI 1.2–6.0, P 
0.003) (supplementary Table A2), and
IDI was 0.2% (0.0–0.3, P  0.03), indi-
cating that the addition of 2-h postpran-
dial glucose into prediction models
would marginally improve discriminative
ability of the models.
Assessed by the use of the Hosmer-
Lemeshowtest,themodelswith2-hpost-
prandial glucose had smaller a 
2 statistic
than those without 2-h postprandial glu-
cose, for predicting both cardiovascular
death and all-cause death (Table 3).
Moreover, all models with and without
2-h postprandial glucose represented ad-
equate calibration.
CONCLUSIONS — In this study we
investigated the independent and incre-
mental utility of 2-h postprandial glucose
in risk prediction for cardiovascular and
all-cause death in the nondiabetic popu-
lation. Our data demonstrated that in-
creased 2-h postprandial glucose was an
independent risk predictor of cardiovas-
cular and all-cause death and that the ad-
dition of 2-h postprandial glucose into
riskprediction,whichincludesmetabolic
syndrome status and established cardio-
vascular risk factors, could improve the
predictiveabilityoftheriskforcardiovas-
cular death.
Postprandial hyperglycemia differs
fromfastinghyperglycemiainpathophys-
iology and the risk of adverse outcomes.
Postprandial hyperglycemia results
mainly from a moderate to severe de-
crease in muscle insulin sensitivity and
late-phase insulin secretory response to
oral glucose; whereas fasting hyperglyce-
mia results mainly from a defect in he-
patic insulin sensitivity and ﬁrst-phase
insulin response (16). Our ﬁndings con-
cur with those of a meta-analysis of 38
prospective studies, which demonstrated
that nondiabetic postprandial hypergly-
cemiasigniﬁcantlyraisesthelikelihoodof
cardiovascular events or death and that
the relationship remains after cardiovas-
cular risk factors have been adjusted for
(17). The underlying pathobiological
changes linking elevated postprandial
glucose and cardiovascular diseases con-
sistmainlyofelevatedoxidativestressand
endothelial dysfunction, leading to
atherothombotic propensities of elevated
postprandialglucose,suchasoxidationof
LDL cholesterol, vasoconstriction, and
thrombogenicity (18). Moreover, inter-
ventions targeting elevated postprandial
glucose are of clinical signiﬁcance for op-
timizing comprehensive glycemic control
in individuals with diabetes and with im-
pairedglucoseregulationtolowertherisk
of adverse outcomes (19).
It has been shown that the mixed-
mealtestiswellcorrelatedwiththeOGTT
in measures of insulin sensitivity and is
more likely to have a stronger pancreatic
-cellresponsetoanequalamountofcar-
bohydrate than the OGTT (7), perhaps
suggesting that a mixed-meal test could
bemoresuitableforevaluatingthereserve
of insulin secretion. Evidence has
emerged about the association between
postmeal glucose concentrations and the
cardiovascular risk. In women with nor-
mal glucose regulation, those with ele-
vated postmeal postprandial glucose tend
to have increased carotid intima medial
thickness(20).Inarecentstudyassessing
the relationship between postmeal glu-
cose and incident cardiovascular compli-
cations, it was reported that elevated
postmeal glucose, but not fasting glucose,
predisposes patients with type 2 diabetes
to increased cardiovascular risk (21).
There is also growing interest in the in-
creased risk of cardiovascular events in
relation to postprandial lipid concentra-
tions, which were obtained after normal
food intake (22,23).
Some limitations and weakness in
this study need careful concern. First,
BMI, rather than waist circumference,
was used as the obesity criterion of meta-
bolic syndrome in this study. However,
ﬁndings from previous studies have con-
ﬁrmed that, in this setting, using either
BMI or waist circumference leads to no
difference in predicting cardiovascular
events (24). Second, the NRI method is
affected by the risk categories used, and
no consensus had existed on clinically
signiﬁcant risk categories of cardiovascu-
lar death when our analysis was con-
ducted. Nonetheless, the improvement in
reclassiﬁcation for cardiovascular death
was corroborated by the use of IDI, a
method with no ﬁxed cutoffs for risk cat-
egorization (13). Third, caution should
be taken in generalizing our results to a
community-based population because
this study cohort was based on partici-
pants undergoing health check-ups at a
university hospital. Fourth, compared
with the survey in the general population
including individuals with diabetes, the
incidence of cardiovascular death seemed
tobelowinourstudy,partlybecauseonly
individuals without diabetes were in-
cluded. Thus, one should be cautious
when the relative risks with wide CIs are
considered.
Despite these concerns, our ﬁndings
provide evidence that elevated postpran-
dial glucose independently posed height-
ened risks of cardiovascular and all-cause
death and that the inclusion of postpran-
dial glucose into risk prediction for car-
diovascular death increases the risk
predictiveability.Futuretrialstoexamine
the difference in the risk of adverse out-
comes between deﬁnitions of metabolic
syndrome using fasting or postprandial
nonfasting glucose and lipid criteria may
be of clinical interest.
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